Malaria is the 5th responsible cause of death from infectious disease worldwide, and approximately half the global population are at risk. 1A team of scientists in Missouri, USA3 has recently answered a long-standing question regarding the metabolism of the parasite, advancing research towards identifying novel therapeutics
Malaria is the 5th biggest killer worldwide and approximately half the global population are at risk1. The causativeagent of malaria, the parasite Plasmodiumfalciparum, is transmitted via the bite of aninfected Anopheles mosquito. Followingtransmission, the parasite is transportedvia the blood stream to the liver whereit multiplies and subsequently infects redblood cells (RBC’s) at the so-called bloodinfection stage2.
A team of scientists in Missouri, USA,3 hasrecently answered a long-standing questionregarding the metabolism of the parasite,advancing research towards identifyingnovel therapeutic targets.
To analyse the reaction products resultingfrom in vitro parasitic heme degradationpathways, a range of chromatographictechniques were used. HPLC (highperformance liquid chromatography)coupled to high resolution massspectrometry was used for the analysis ofreaction products generated during in vitroheme degradation; and both affinity andsize-exclusion chromatography were usedfor protein purification.
The leading author of the study, PaulSigala, told The Column: “Human infectionby Plasmodium falciparum parasites, thecausative agent of malaria, remains asevere public health problem worldwideand a better understanding of parasitemetabolism can clarify what are or are notappropriate therapeutic targets. Duringthe blood-infection stage, the parasitemust deal with a vast amount of heme,most of which is derived from digestion ofthe hemoglobin within red blood cells. Ithas remained unclear whether a portionof this heme is enzymatically processed byparasites for utilization or disposal. Ourstudy thus clarifies a fundamental aspectof parasite biology, which will focus effortson remaining pathways that are operativewithin parasites.”
It is hoped that these findings willadvance the understanding of malariacausing parasite transmission, furtheradvancing progress towards theidentification of valid therapeutic targets.
1. Centre for Disease Control, www.cdc.gov/malaria/about/facts.html (Accessed24th of September 2012).
2. World Health Organization: www.who.int/topics/malaria/en/ (Accessed 24th ofSeptember 2012).
3. Paul A. Sigala et al., The Journalof Biological Chemistry, DOI:10.1074/jbc.M112.414078(2012).
This story originally appeared in The Column. Click here to view that issue.
Liquid Chromatography to Analyze Vitamin D Proteins in Psoriasis Patients
January 21st 2025Can a protein involved in delivering Vitamin D to target tissues have an altered serum profile in psoriasis patients with cardiovascular disease? Researchers used liquid chromatography (LC) to help find out.
The Next Frontier for Mass Spectrometry: Maximizing Ion Utilization
January 20th 2025In this podcast, Daniel DeBord, CTO of MOBILion Systems, describes a new high resolution mass spectrometry approach that promises to increase speed and sensitivity in omics applications. MOBILion recently introduced the PAMAF mode of operation, which stands for parallel accumulation with mobility aligned fragmentation. It substantially increases the fraction of ions used for mass spectrometry analysis by replacing the functionality of the quadrupole with high resolution ion mobility. Listen to learn more about this exciting new development.
The Complexity of Oligonucleotide Separations
January 9th 2025Peter Pellegrinelli, Applications Specialist at Advanced Materials Technology (AMT) explains the complexity of oligonucleotide separations due to the unique chemical properties of these molecules. Issues such as varying length, sequence complexity, and hydrophilic-hydrophobic characteristics make efficient separations difficult. Separation scientists are addressing these challenges by modifying mobile phase compositions, using varying ion-pairing reagents, and exploring alternative separation modes like HILIC and ion-exchange chromatography. Due to these complexities, AMT has introduced the HALO® OLIGO column, which offers high-resolution, fast separations through its innovative Fused-Core® technology and high pH stability. Alongside explaining the new column, Peter looks to the future of these separations and what is next to come.
Oasis or Sand Dune? Isolation of Psychedelic Compounds
January 20th 2025Magic mushrooms, once taboo, have recently experienced a renaissance. This new awakening is partially due to new findings that indicate the effects of psilocybin, and its dephosphorylated cousin psilocin may produce long lasting results for patients who might be struggling with anxiety, depression, alcohol and drug abuse, and post-traumatic stress disorder. Hamilton Company has developed a methodology for the isolation and identification of 5 common psychedelic compounds used in the potential treatment of disease. The PRP-1 HPLC column resin remains stable in the harsh alkaline conditions ideal for better separations.